Our Team
We are united by a shared purpose: to advance human health through scientific excellence, operational rigor, and entrepreneurial vision. Our leadership team brings together decades of expertise to turn scientific innovation into patient impact.
Co-Founder, Chief Scientific Officer
Yong Du has over 30 years of experience in the research and development of biologics, leading or participating in the development of multiple therapeutic protein drugs, recombinant antibody drugs, and nucleic acid drugs. His expertise in immunology, oncology, and translational research continues to drive innovation across our programs.
Yong Du
Chief Medical Officer
Yali Ren has over 17 years of leadership experience spanning biologics R&D, medical and regulatory affairs, and corporate management, leading with a commitment to scientific excellence, innovation, and cross-functional leadership.
Yali Ren
Chief Manufacturing Officer
Wenxue Zhang has extensive experience in the development of biological products, manufacturing scale-up, establishment of commercial-scale production platforms, and management and operations, bringing deep operational expertise and a proven record in biopharmaceutical manufacturing and commercialization.
Wenxue Zhang
Chief Planning Officer
Zhou Jianjun is a leader in clinical medicine, research, and biopharmaceutical innovation with over 20 years of experience spanning new product development and project management across hospitals, academic institutions, and industry. Throughout his career, he has held roles as a clinician, research scientist, and R&D director, bringing cross-sector expertise and extensive strategic partnerships with leading biopharmaceutical companies and major hospital networks.